Company / Interest Expense
LivaNova Interest Expense History
FY2016-FY2023 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Interest Expense
$58.9M
FY2023
5-year range
$15.1M / $58.9M
FY2019-FY2023
Trend
+44.1%
vs FY2022
Sector context
#25 of 43
Health Care
What the data says
At $59M, LivaNova's interest expense ranks #19 of 43 in the Health Care sector. Interest Expense has fluctuated over the past 8 years, ranging from $8M in FY2017 to $59M in FY2023.
Based on SEC 10-K filings.
$59M in FY2023 with a 5-year CAGR of +43.0%.
Increased from $15M to $59M over the past 2 years.
Health Care sector context is included.
Interest Expense over time
Growth rates
- 3-Year CAGR
- +13.0%
- 5-Year CAGR
- +43.0%
- 10-Year CAGR
- -
Sector benchmark
#19 of 43 in Health CareTop 42% of 43This company $58.9M Sector average $324.8M
▼
-81.9% below sector average
Key checks
Key Insights
- 5-year CAGR of +43.0%, indicating consistent growth.
- In FY2023, interest expense increased 44.1% year-over-year.
- Ranks #25 out of 43 companies in the Health Care sector.
- Lowest interest expense in the period was in FY2017.
Company context
Key Data Points
- Altman Z-Score 0.84 (distress zone, below 1.8 threshold)
- Negative profit margin: -16.1%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Interest ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | $58.9M | +44.1% |
| FY2022 | $40.8M | +170.6% |
| FY2021 | $15.1M | -63.0% |
| FY2020 | $40.8M | +170.6% |
| FY2019 | $15.1M | +53.6% |
| FY2018 | $9.8M | +26.0% |
| FY2017 | $7.8M | -26.6% |
| FY2016 | $10.6M | +603.5% |
As of FY2023 · SEC 10-K · Updated Jun 30, 2026